Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (NYSE: NVO)

 
NVO Technical Analysis
5
As on 2nd May 2025 NVO SHARE Price closed @ 69.23 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 123.92 & Strong Sell for SHORT-TERM with Stoploss of 103.30 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NVOSHARE Price

Open 69.75 Change Price %
High 69.86 1 Day 3.63 5.53
Low 68.53 1 Week 7.93 12.94
Close 69.23 1 Month -9.56 -12.13
Volume 13111273 1 Year -29.97 -30.21
52 Week High 146.91 | 52 Week Low 58.08
 
NYSE USA Most Active Stocks
FSR 0.02 0.00%
DDR 15.44 -4.46%
TWTR 53.70 0.66%
SWN 7.11 -0.56%
PLTR 124.28 6.95%
BACA-U 302.00 0.67%
ENLC 14.12 -0.21%
WOLF 4.46 23.89%
SNAP 8.45 7.92%
F 10.28 0.98%
 
NYSE USA Top Gainers Stocks
CND-WT 0.05 400.00%
WEI 0.44 51.72%
QFTA 10.26 51.33%
MOTV 18.70 50.20%
CORR 0.03 50.00%
CPS 21.88 43.76%
CPS 21.88 43.76%
CPS 21.88 43.76%
WE 0.50 42.86%
WE 0.50 42.86%
 
NYSE USA Top Losers Stocks
AJX 0.01 -99.67%
AJX 0.01 -99.67%
AJX 0.01 -99.67%
QFTA-WS 0.46 -95.33%
TWND-WS 0.48 -95.12%
CHAA-WS 0.53 -94.56%
PMVC-WS 0.58 -94.10%
PIAI-WS 0.58 -94.09%
PCPC-WS 1.50 -93.83%
FTEV-WS 0.60 -93.81%
 
 
NVO
Daily Charts		 NVO
Intraday Charts		 Whats New @
Bazaartrend		 NVO
Free Analysis
 
NVO Important Levels Intraday
RESISTANCE71.79
RESISTANCE70.97
RESISTANCE70.46
RESISTANCE69.95
SUPPORT68.51
SUPPORT68.00
SUPPORT67.49
SUPPORT66.67
 
NVO Forecast May 2025
Share
4th UP Forecast90.35
3rd UP Forecast83.58
2nd UP Forecast79.39
1st UP Forecast75.2
1st DOWN Forecast63.26
2nd DOWN Forecast59.07
3rd DOWN Forecast54.88
4th DOWN Forecast48.11
 
NVO Weekly Forecast
4th UP Forecast78.54
3rd UP Forecast75.55
2nd UP Forecast73.71
1st UP Forecast71.86
1st DOWN Forecast66.60
2nd DOWN Forecast64.75
3rd DOWN Forecast62.91
4th DOWN Forecast59.92
 
NVO Forecast2025
4th UP Forecast244.88
3rd UP Forecast188.55
2nd UP Forecast153.73
1st UP Forecast118.91
1st DOWN Forecast19.55
2nd DOWN Forecast-15.27
3rd DOWN Forecast-50.09
4th DOWN Forecast-106.42
 
 
NVO Other Details
Segment EQ
Market Capital 247091216384.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NVO Address
NVO
 
NVO Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NVO Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service